TipRanks
Go Ultimate55% OFF

Alnylam Pharma (0HD2) Cash flow

Alnylam Pharma Cash Flow

GB:0HD2's free cash flow for Q3 2026 was $271.15M. For the 2026 fiscal year, GB:0HD2's free cash flow was decreased by $-69.83M and operating cash flow was $340.99M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ 524.08M$ -8.31M$ 104.16M$ -541.27M$ -641.69M
$ 436.33M$ -116.84M$ -336.35M$ 169.35M$ -273.30M
$ -305.19M$ 294.16M$ 172.13M$ 425.75M$ 1.25B
$ 1.66B$ 968.65M$ 814.88M$ 868.56M$ 822.15M
$ 465.38M$ -42.59M$ 41.95M$ -613.33M$ -718.07M

Currency in USD

Alnylam Pharma Cash Flow

-1B-500M0500M1B1.5B201720182019202020212022202320242025OperatingInvestingFinancing